跳到正文
原文
Endpoints News 生物医药· Lei Lei Wu·· 15 天前AI 评分35

Kamau 共享其改良型镰状细胞基因编辑疗法初步临床数据

#ASH26: Kamau shares first data from revamped sickle cell gene editing therapy

AI 导读

Kamau Therapeutics 共享了其改良型镰状细胞基因编辑疗法的初步临床数据。该数据尚未经过同行评审,显示了初步的安全性和有效性。

正文

Ka­mau Ther­a­peu­tics, which has stayed rel­a­tive­ly qui­et since its 2023 emer­gence, is shar­ing clin­i­cal da­ta from its re­vamped sick­le cell gene edit­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news